Commit To Buy Avalanche Biotechnologies At $5, Earn 24.1% Annualized Using Options
May 03, 2016 at 11:46 AM EDT
Investors eyeing a purchase of Avalanche Biotechnologies, Inc. (AAVL) stock, but cautious about paying the going market price of $5.51/share, might benefit from considering selling puts among the alternative strategies at their disposal..
